​

Fortrea (FTRE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FTRE Stock Forecast

Fortrea (FTRE) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $10.50, with a high of $14.00 and a low of $8.00. This represents a -1.13% decline from the last price of $10.62.

$5 $13 $21 $29 $37 $45 High: $14 Avg: $10.5 Low: $8 Last Closed Price: $10.62

FTRE Stock Rating

Fortrea stock's rating consensus is Hold, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (9.09%), 8 Hold (72.73%), 2 Sell (18.18%), and 0 Strong Sell (0.00%).

Hold
Total 11 0 2 8 1 Strong Sell Sell Hold Buy Strong Buy

FTRE Price Target Upside V Benchmarks

TypeNameUpside
StockFortrea-1.13%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts358
Avg Price Target$9.33$9.60$12.13
Last Closing Price$10.62$10.62$10.62
Upside/Downside-12.15%-9.60%14.22%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25118-212
Sep, 25118-212
Aug, 25-19-212
Jul, 25-19-212
Jun, 25-110-213
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 17, 2025Mizuho Securities$9.00$9.52-5.46%-15.25%
Oct 08, 2025Elizabeth AndersonEvercore ISI$11.00$9.3118.15%3.58%
Oct 02, 2025Barclays$8.00$9.52-15.97%-24.67%
Sep 03, 2025Eric ColdwellRobert W. Baird$14.00$10.7630.11%31.83%
Aug 07, 2025Luke SergottBarclays$6.00$6.58-8.81%-43.50%
Mar 04, 2025Robert W. Baird$12.00$10.969.49%12.99%
Mar 04, 2025Barclays$12.00$10.969.49%12.99%
Nov 08, 2024Luke SergottBarclays$25.00$17.0146.97%135.40%
Aug 13, 2024Elizabeth AndersonEvercore ISI$22.00$20.049.78%107.16%
Aug 08, 2024Elizabeth AndersonEvercore ISI$27.00$24.579.89%154.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 07, 2025CitigroupNeutralNeutralhold
Oct 02, 2025BarclaysUnderweightUnderweighthold
Sep 09, 2025JefferiesHoldHoldhold
Aug 07, 2025BarclaysUnderweightUnderweighthold
May 22, 2025CitigroupNeutralNeutralhold
May 14, 2025Cowen & Co.HoldHoldhold
May 13, 2025BarclaysUnderweightUnderweighthold
Dec 11, 2024CitigroupBuyNeutraldowngrade
Nov 11, 2024Cowen & Co.HoldHoldhold
Sep 25, 2024JefferiesBuyHolddowngrade

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.04$-3.67----
Avg Forecast$1.44$0.51$1.29$1.72$2.30$2.96
High Forecast$1.47$0.55$1.52$2.09$2.41$3.06
Low Forecast$1.40$0.46$1.10$1.46$2.20$2.92
Surprise %-102.78%-819.61%----

Revenue Forecast

$3B $3B $3B $3B $3B $3B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.11B$2.70B----
Avg Forecast$3.11B$2.70B$2.73B$2.85B$2.97B$3.19B
High Forecast$3.12B$2.78B$2.78B$2.86B$3.01B$3.27B
Low Forecast$3.08B$2.67B$2.71B$2.84B$2.94B$3.15B
Surprise %-0.12%-0.23%----

Net Income Forecast

$-350M $-220M $-90M $40M $170M $300M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.40M$-328.50M----
Avg Forecast$127.73M$45.08M$116.21M$157.70M$204.37M$262.85M
High Forecast$130.84M$49.10M$134.61M$185.86M$213.61M$272.12M
Low Forecast$124.61M$41.06M$97.82M$129.54M$195.13M$258.96M
Surprise %-102.66%-828.71%----

FTRE Forecast FAQ

Is Fortrea stock a buy?

Fortrea stock has a consensus rating of Hold, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Fortrea is a neutral investment for most analysts.

What is Fortrea's price target?

Fortrea's price target, set by 11 Wall Street analysts, averages $10.5 over the next 12 months. The price target range spans from $8 at the low end to $14 at the high end, suggesting a potential -1.13% change from the previous closing price of $10.62.

How does Fortrea stock forecast compare to its benchmarks?

Fortrea's stock forecast shows a -1.13% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Fortrea over the past three months?

  • October 2025: 8.33% Strong Buy, 8.33% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • September 2025: 8.33% Strong Buy, 8.33% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.
  • August 2025: 0% Strong Buy, 8.33% Buy, 75.00% Hold, 0% Sell, 16.67% Strong Sell.

What is Fortrea’s EPS forecast?

Fortrea's average annual EPS forecast for its fiscal year ending in December 2025 is $1.29, marking a -135.15% decrease from the reported $-3.67 in 2024. Estimates for the following years are $1.72 in 2026, $2.3 in 2027, and $2.96 in 2028.

What is Fortrea’s revenue forecast?

Fortrea's average annual revenue forecast for its fiscal year ending in December 2025 is $2.73B, reflecting a 1.22% increase from the reported $2.7B in 2024. The forecast for 2026 is $2.85B, followed by $2.97B for 2027, and $3.19B for 2028.

What is Fortrea’s net income forecast?

Fortrea's net income forecast for the fiscal year ending in December 2025 stands at $116.21M, representing a -135.38% decrease from the reported $-328M in 2024. Projections indicate $157.7M in 2026, $204.37M in 2027, and $262.85M in 2028.